Some recent studies reported that TIMD4 had a correlation with some malignant carcinomas and its upregulation might lead to poor prognosis, as in diffuse large B-cell lymphoma and non-small-cell carcinoma [41]. This evidence concerns the gene TIMD4 and diffuse large B-cell lymphoma.